- Rino
Rappuoli ForMemRS (born 4
August 1952) is an
Italian immunologist. He is the head of
vaccine research and
development (R&D) at
GlaxoSmithKline (GSK)...
-
employs bioinformatics and
reverse pharmacology practices,
pioneered by Rino
Rappuoli and
first used
against Serogroup B meningococcus.
Since then, it has been...
-
squalene based adjuvant O’Hagan,
Derek T; Ott, Gary S; Nest, Gary Van;
Rappuoli, Rino; Giudice,
Giuseppe Del (2014). "The
history of MF59® adjuvant: a...
- Alessandro; Monaci, Ernesto; Bagnoli, Franco; Iavarone, Claudia; O'Hagan, Derek;
Rappuoli, Rino; De Gregorio,
Ennio (29 July 2008). "Molecular and
cellular signatures...
- 1155–64. doi:10.1086/339409. PMID 11930326. Good MF,
Levine MA,
Kaper JB,
Rappuoli R, Liu MA (2004). New
Generation Vaccines. New York, N.Y:
Marcel Dekker...
-
sophisticated bacterial cells are. Cossart, P.; Boquet, P.; Normark, S.;
Rappuoli, R. (1996). "Cellular
Microbiology Emerging". Science. 271 (5247): 315–316...
- 2010-05-29.
Vaccine design :
innovative approaches and
novel strategies.
Rappuoli, Rino., Bagnoli, Fabio. Norfolk, UK:
Caister Academic. 2011. ISBN 9781904455745...
- doi:10.1016/S0140-6736(13)60177-4. PMC 5424647. PMID 23391465.
Delany I,
Rappuoli R, De
Gregorio E (June 2014). "Vaccines for the 21st century". EMBO Molecular...
- 2018-10-18.
Archived from the
original on 2020-01-02.
Retrieved 2018-11-29.
Rappuoli, Rino.; Bagnoli, Fabio., eds. (2011).
Vaccine design :
innovative approaches...
-
group B vaccine". Medscape. WebMD.
Retrieved December 16, 2015. Seib KL,
Rappuoli R (2010). "Difficulty in
Developing a
Neisserial Vaccine". Neisseria: Molecular...
